Connection

STEPHEN PFLUGFELDER to Male

This is a "connection" page, showing publications STEPHEN PFLUGFELDER has written about Male.
Connection Strength

0.855
  1. Orbital Richter Transformation With Subsequent Orbital MALT-type Lymphoma in a Patient With Chronic Lymphocytic Leukemia. Ophthalmic Plast Reconstr Surg. 2024 Nov-Dec 01; 40(6):e205-e209.
    View in: PubMed
    Score: 0.029
  2. Conjunctivochalasis and Tear Osmolarity Are Associated With Reduced Conjunctival Epithelial Thickness in Dry Eye. Am J Ophthalmol. 2021 07; 227:35-44.
    View in: PubMed
    Score: 0.023
  3. Regional Comparison of Goblet Cell Number and Area in Exposed and Covered Dry Eyes and Their Correlation with Tear MUC5AC. Sci Rep. 2020 02 19; 10(1):2933.
    View in: PubMed
    Score: 0.021
  4. Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial. Ophthalmology. 2020 01; 127(1):14-26.
    View in: PubMed
    Score: 0.020
  5. Goblet cell loss abrogates ocular surface immune tolerance. JCI Insight. 2018 02 08; 3(3).
    View in: PubMed
    Score: 0.018
  6. Randomized Controlled Crossover Trial Comparing the Impact of Sham or Intranasal Tear Neurostimulation on Conjunctival Goblet Cell Degranulation. Am J Ophthalmol. 2017 May; 177:159-168.
    View in: PubMed
    Score: 0.017
  7. Aqueous Tear Deficiency Increases Conjunctival Interferon-? (IFN-?) Expression and Goblet Cell Loss. Invest Ophthalmol Vis Sci. 2015 Nov; 56(12):7545-50.
    View in: PubMed
    Score: 0.016
  8. Corneal Sensitivity in Tear Dysfunction and its Correlation With Clinical Parameters and Blink Rate. Am J Ophthalmol. 2015 Nov; 160(5):858-866.e5.
    View in: PubMed
    Score: 0.015
  9. Effects of Dry Eye Therapies on Environmentally Induced Ocular Surface Disease. Am J Ophthalmol. 2015 Jul; 160(1):135-42.e1.
    View in: PubMed
    Score: 0.015
  10. Atopic keratoconjunctivitis: A review. J Am Acad Dermatol. 2014 Mar; 70(3):569-75.
    View in: PubMed
    Score: 0.014
  11. Topical interferon-gamma neutralization prevents conjunctival goblet cell loss in experimental murine dry eye. Exp Eye Res. 2014 Jan; 118:117-24.
    View in: PubMed
    Score: 0.014
  12. Tear meniscus dimensions in tear dysfunction and their correlation with clinical parameters. Am J Ophthalmol. 2014 Feb; 157(2):301-310.e1.
    View in: PubMed
    Score: 0.014
  13. Factors predicting the ocular surface response to desiccating environmental stress. Invest Ophthalmol Vis Sci. 2013 May 07; 54(5):3325-32.
    View in: PubMed
    Score: 0.013
  14. PROSE therapy used to minimize corneal trauma in patients with corneal epithelial defects. Am J Ophthalmol. 2013 Apr; 155(4):615-619, 619.e1-2.
    View in: PubMed
    Score: 0.013
  15. Increasing prevalence and severity of conjunctivochalasis with aging detected by anterior segment optical coherence tomography. Am J Ophthalmol. 2013 Feb; 155(2):238-242.e2.
    View in: PubMed
    Score: 0.013
  16. Botulinum toxin injection for the management of refractory filamentary keratitis. Arch Ophthalmol. 2012 Apr; 130(4):446-50.
    View in: PubMed
    Score: 0.012
  17. Entrapment of conjunctival goblet cells by desiccation-induced cornification. Invest Ophthalmol Vis Sci. 2011 Jun 01; 52(6):3492-9.
    View in: PubMed
    Score: 0.012
  18. The impact of the Boston ocular surface prosthesis on wavefront higher-order aberrations. Am J Ophthalmol. 2011 Apr; 151(4):682-690.e2.
    View in: PubMed
    Score: 0.011
  19. Noninvasive assessment of tear stability with the tear stability analysis system in tear dysfunction patients. Invest Ophthalmol Vis Sci. 2011 Jan; 52(1):456-61.
    View in: PubMed
    Score: 0.011
  20. The successful use of Boston ocular surface prosthesis in the treatment of persistent corneal epithelial defect after herpes zoster ophthalmicus. Cornea. 2010 Dec; 29(12):1465-8.
    View in: PubMed
    Score: 0.011
  21. Anterior segment optical coherence tomography: a diagnostic instrument for conjunctivochalasis. Am J Ophthalmol. 2010 Dec; 150(6):798-806.
    View in: PubMed
    Score: 0.011
  22. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis. Cornea. 2010 Aug; 29(8):871-7.
    View in: PubMed
    Score: 0.011
  23. Altered morphology and function of the lacrimal functional unit in protein kinase C{alpha} knockout mice. Invest Ophthalmol Vis Sci. 2010 Nov; 51(11):5592-600.
    View in: PubMed
    Score: 0.011
  24. Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway. Invest Ophthalmol Vis Sci. 2010 Jun; 51(6):3083-91.
    View in: PubMed
    Score: 0.011
  25. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol. 2010 Jan; 128(1):94-101.
    View in: PubMed
    Score: 0.010
  26. Corneal nerve regeneration in neurotrophic keratopathy following autologous plasma therapy. Br J Ophthalmol. 2010 May; 94(5):584-91.
    View in: PubMed
    Score: 0.010
  27. Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. Invest Ophthalmol Vis Sci. 2010 Feb; 51(2):643-50.
    View in: PubMed
    Score: 0.010
  28. Association between high tear epidermal growth factor levels and corneal subepithelial fibrosis in dry eye conditions. Invest Ophthalmol Vis Sci. 2010 Feb; 51(2):844-9.
    View in: PubMed
    Score: 0.010
  29. Corneal epithelial opacity in dysfunctional tear syndrome. Am J Ophthalmol. 2009 Sep; 148(3):376-82.
    View in: PubMed
    Score: 0.010
  30. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci. 2009 Jul; 50(7):3203-9.
    View in: PubMed
    Score: 0.010
  31. IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol. 2009 May; 2(3):243-53.
    View in: PubMed
    Score: 0.010
  32. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009 Feb; 147(2):198-205. e1.
    View in: PubMed
    Score: 0.010
  33. Desiccating stress decreases apical corneal epithelial cell size--modulation by the metalloproteinase inhibitor doxycycline. Cornea. 2008 Sep; 27(8):935-40.
    View in: PubMed
    Score: 0.010
  34. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production. Cornea. 2008 Jan; 27(1):64-9.
    View in: PubMed
    Score: 0.009
  35. Desiccating environmental stress exacerbates autoimmune lacrimal keratoconjunctivitis in non-obese diabetic mice. J Autoimmun. 2008 Jun; 30(4):212-21.
    View in: PubMed
    Score: 0.009
  36. Expression of Th-1 chemokines and chemokine receptors on the ocular surface of C57BL/6 mice: effects of desiccating stress. Invest Ophthalmol Vis Sci. 2007 Jun; 48(6):2561-9.
    View in: PubMed
    Score: 0.009
  37. Strain-related cytokine profiles on the murine ocular surface in response to desiccating stress. Cornea. 2007 Jun; 26(5):579-84.
    View in: PubMed
    Score: 0.009
  38. Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice. Eye Contact Lens. 2006 Dec; 32(6):272-6.
    View in: PubMed
    Score: 0.008
  39. Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium. Invest Ophthalmol Vis Sci. 2006 Aug; 47(8):3293-302.
    View in: PubMed
    Score: 0.008
  40. The incidence and risk factors for developing dry eye after myopic LASIK. Am J Ophthalmol. 2006 Mar; 141(3):438-45.
    View in: PubMed
    Score: 0.008
  41. Therapy of progressive rheumatoid arthritis-associated corneal ulceration with infliximab. Cornea. 2005 Aug; 24(6):742-4.
    View in: PubMed
    Score: 0.008
  42. Effect of experimental dry eye on tear sodium concentration in the mouse. Eye Contact Lens. 2005 Jul; 31(4):175-8.
    View in: PubMed
    Score: 0.008
  43. Mucous membrane pemphigoid in a patient with chronic lymphocytic leukemia. Cornea. 2004 Oct; 23(7):740-3.
    View in: PubMed
    Score: 0.007
  44. Mouse Corneal Immune Cell Heterogeneity Revealed by Single-Cell RNA Sequencing. Invest Ophthalmol Vis Sci. 2024 Oct 01; 65(12):29.
    View in: PubMed
    Score: 0.007
  45. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol. 2004 Sep; 138(3):444-57.
    View in: PubMed
    Score: 0.007
  46. Addressing corneal opacity after herpes zoster infection. J Cataract Refract Surg. 2024 Jun 01; 50(6):655-659.
    View in: PubMed
    Score: 0.007
  47. Corneal epitheliopathy of dry eye induces hyperesthesia to mechanical air jet stimulation. Am J Ophthalmol. 2004 Jan; 137(1):109-15.
    View in: PubMed
    Score: 0.007
  48. Recombinant human tumor necrosis factor receptor Fc fusion protein (Etanercept): experience as a therapy for sight-threatening scleritis and sterile corneal ulceration. Eye Contact Lens. 2004 Jan; 30(1):2-5.
    View in: PubMed
    Score: 0.007
  49. Assessing the severity of keratitis sicca with videokeratoscopic indices. Ophthalmology. 2003 Jun; 110(6):1102-9.
    View in: PubMed
    Score: 0.007
  50. Keratoconus-like topographic changes in keratoconjunctivitis sicca. Cornea. 2003 Jan; 22(1):22-4.
    View in: PubMed
    Score: 0.006
  51. Corneal thickness indices discriminate between keratoconus and contact lens-induced corneal thinning. Ophthalmology. 2002 Dec; 109(12):2336-41.
    View in: PubMed
    Score: 0.006
  52. A multicenter report of the use of plasma rich in growth factors (PRGF) for the treatment of patients with ocular surface diseases in North America. Ocul Surf. 2022 07; 25:40-48.
    View in: PubMed
    Score: 0.006
  53. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001 Sep; 42(10):2283-92.
    View in: PubMed
    Score: 0.006
  54. Single-Cell Transcriptomics Identifies a Unique Entity and Signature Markers of Transit-Amplifying Cells in Human Corneal Limbus. Invest Ophthalmol Vis Sci. 2021 07 01; 62(9):36.
    View in: PubMed
    Score: 0.006
  55. Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface. Ophthalmology. 2001 Jul; 108(7):1230-5.
    View in: PubMed
    Score: 0.006
  56. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids. Am J Ophthalmol. 2001 Jul; 132(1):8-13.
    View in: PubMed
    Score: 0.006
  57. Correlation of the Schirmer 1 and fluorescein clearance tests with the severity of corneal epithelial and eyelid disease. Arch Ophthalmol. 2000 Dec; 118(12):1632-8.
    View in: PubMed
    Score: 0.006
  58. The effects of experimental tear film removal on corneal surface regularity and barrier function. Ophthalmology. 2000 Sep; 107(9):1754-60.
    View in: PubMed
    Score: 0.005
  59. [The abnormal expression of epidermal growth factor receptor family in pterygium]. Zhonghua Yan Ke Za Zhi. 2000 Sep; 36(5):372-4, 25.
    View in: PubMed
    Score: 0.005
  60. Systemic anti-inflammatory therapy aided by double-headed nanoparticles in a canine model of acute intraocular inflammation. Sci Adv. 2020 08; 6(35):eabb7878.
    View in: PubMed
    Score: 0.005
  61. A standardized visual scale for evaluation of tear fluorescein clearance. Ophthalmology. 2000 Jul; 107(7):1338-43.
    View in: PubMed
    Score: 0.005
  62. [The effect of artificial tears on corneal surface regularity in dry eye]. Zhonghua Yan Ke Za Zhi. 2000 Mar; 36(2):131-4.
    View in: PubMed
    Score: 0.005
  63. The effects of long-term contact lens wear on corneal thickness, curvature, and surface regularity. Ophthalmology. 2000 Jan; 107(1):105-11.
    View in: PubMed
    Score: 0.005
  64. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci. 1999 Oct; 40(11):2506-12.
    View in: PubMed
    Score: 0.005
  65. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sj?gren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999 Sep; 19(3):201-11.
    View in: PubMed
    Score: 0.005
  66. Evaluation of corneal thickness and topography in normal eyes using the Orbscan corneal topography system. Br J Ophthalmol. 1999 Jul; 83(7):774-8.
    View in: PubMed
    Score: 0.005
  67. Corneal thickness is reduced in dry eye. Cornea. 1999 Jul; 18(4):403-7.
    View in: PubMed
    Score: 0.005
  68. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency. Ophthalmology. 1999 May; 106(5):939-43.
    View in: PubMed
    Score: 0.005
  69. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sj?gren syndrome. Ophthalmology. 1999 Apr; 106(4):811-6.
    View in: PubMed
    Score: 0.005
  70. Reduced Corneal Innervation in the CD25 Null Model of Sj?gren Syndrome. Int J Mol Sci. 2018 Nov 30; 19(12).
    View in: PubMed
    Score: 0.005
  71. Sj?gren-Like Lacrimal Keratoconjunctivitis in Germ-Free Mice. Int J Mol Sci. 2018 Feb 13; 19(2).
    View in: PubMed
    Score: 0.005
  72. Assessment of the Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) scleral lens on visual acuity for corneal irregularity and ocular surface disease. Ocul Surf. 2018 04; 16(2):254-258.
    View in: PubMed
    Score: 0.005
  73. Reduced intraepithelial corneal nerve density and sensitivity accompany desiccating stress and aging in C57BL/6 mice. Exp Eye Res. 2018 04; 169:91-98.
    View in: PubMed
    Score: 0.005
  74. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea. 1998 Jan; 17(1):38-56.
    View in: PubMed
    Score: 0.005
  75. Cytokines and tear function in ocular surface disease. Adv Exp Med Biol. 1998; 438:461-9.
    View in: PubMed
    Score: 0.005
  76. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye. BMC Ophthalmol. 2017 Dec 28; 17(1):265.
    View in: PubMed
    Score: 0.005
  77. Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology. 1997 Nov; 104(11):1868-74.
    View in: PubMed
    Score: 0.005
  78. The effects of age, gender, and fluid dynamics on the concentration of tear film epidermal growth factor. Cornea. 1997 Jul; 16(4):430-8.
    View in: PubMed
    Score: 0.004
  79. Evolving risk factors and antibiotic sensitivity patterns for microbial keratitis at a large county hospital. Br J Ophthalmol. 2017 11; 101(11):1483-1487.
    View in: PubMed
    Score: 0.004
  80. Long-term outcomes of ciliary sulcus versus capsular bag fixation of intraocular lenses in children: An ultrasound biomicroscopy study. PLoS One. 2017; 12(3):e0172979.
    View in: PubMed
    Score: 0.004
  81. Corneal chromoblastomycosis. Cornea. 1997 Mar; 16(2):235-9.
    View in: PubMed
    Score: 0.004
  82. Mitochondrial DNA oxidation induces imbalanced activity of NLRP3/NLRP6 inflammasomes by activation of caspase-8 and BRCC36 in dry eye. J Autoimmun. 2017 Jun; 80:65-76.
    View in: PubMed
    Score: 0.004
  83. A hyaluronan hydrogel scaffold-based xeno-free culture system for ex vivo expansion of human corneal epithelial stem cells. Eye (Lond). 2017 Jun; 31(6):962-971.
    View in: PubMed
    Score: 0.004
  84. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation. Ophthalmology. 1997 Feb; 104(2):223-35.
    View in: PubMed
    Score: 0.004
  85. Cholinergic stimulation of lactoferrin and epidermal growth factor secretion by the human lacrimal gland. Cornea. 1996 Nov; 15(6):617-21.
    View in: PubMed
    Score: 0.004
  86. Interferon-gamma deficiency protects against aging-related goblet cell loss. Oncotarget. 2016 10 04; 7(40):64605-64614.
    View in: PubMed
    Score: 0.004
  87. Transforming growth factor beta-1 and beta-2 in human tear fluid. Curr Eye Res. 1996 Jun; 15(6):605-14.
    View in: PubMed
    Score: 0.004
  88. Production and secretion of transforming growth factor beta (TGF-beta) by the human lacrimal gland. Curr Eye Res. 1996 Jun; 15(6):615-24.
    View in: PubMed
    Score: 0.004
  89. Conjunctival intraepithelial neoplasia. A possible marker for human immunodeficiency virus infection? Arch Ophthalmol. 1996 Mar; 114(3):257-61.
    View in: PubMed
    Score: 0.004
  90. Substrate modulation of morphology, growth, and tear protein production by cultured human lacrimal gland epithelial cells. Exp Cell Res. 1995 Sep; 220(1):138-51.
    View in: PubMed
    Score: 0.004
  91. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sj?gren's syndrome. Arthritis Res Ther. 2015 Mar 10; 17:53.
    View in: PubMed
    Score: 0.004
  92. Adenovirus epithelial keratitis. Cornea. 1995 Mar; 14(2):167-74.
    View in: PubMed
    Score: 0.004
  93. Interpretation of intraocular and serum antibody levels in necrotizing retinitis. Retina. 1995; 15(3):233-40.
    View in: PubMed
    Score: 0.004
  94. Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%. Eye Contact Lens. 2014 Sep; 40(5):289-96.
    View in: PubMed
    Score: 0.004
  95. Complications related to a cosmetic eye-whitening procedure. Am J Ophthalmol. 2014 Nov; 158(5):967-73.
    View in: PubMed
    Score: 0.004
  96. Ocular surface disease and dacryoadenitis in aging C57BL/6 mice. Am J Pathol. 2014 Mar; 184(3):631-43.
    View in: PubMed
    Score: 0.003
  97. Endophthalmitis caused by Staphylococcus aureus. Am J Ophthalmol. 1993 Nov 15; 116(5):584-9.
    View in: PubMed
    Score: 0.003
  98. Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical Trial. Cornea. 2013 Oct; 32(10):1297-304.
    View in: PubMed
    Score: 0.003
  99. Morphologic alterations of the palpebral conjunctival epithelium in a dry eye model. Cornea. 2013 Apr; 32(4):483-90.
    View in: PubMed
    Score: 0.003
  100. Toll-like receptor expression and activation in mice with experimental dry eye. Invest Ophthalmol Vis Sci. 2013 Feb 28; 54(2):1554-63.
    View in: PubMed
    Score: 0.003
  101. Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye. Cornea. 2012 Nov; 31(11):1299-303.
    View in: PubMed
    Score: 0.003
  102. Deletion of interferon-? delays onset and severity of dacryoadenitis in CD25KO mice. Arthritis Res Ther. 2012 Nov 01; 14(6):R234.
    View in: PubMed
    Score: 0.003
  103. Endophthalmitis caused by streptococcal species. Arch Ophthalmol. 1992 Jun; 110(6):798-801.
    View in: PubMed
    Score: 0.003
  104. Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways. J Allergy Clin Immunol. 2011 Dec; 128(6):1318-1325.e2.
    View in: PubMed
    Score: 0.003
  105. Spontaneous autoimmune dacryoadenitis in aged CD25KO mice. Am J Pathol. 2010 Aug; 177(2):744-53.
    View in: PubMed
    Score: 0.003
  106. Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency. Ophthalmology. 1990 Mar; 97(3):313-23.
    View in: PubMed
    Score: 0.003
  107. TSLP and downstream molecules in experimental mouse allergic conjunctivitis. Invest Ophthalmol Vis Sci. 2010 Jun; 51(6):3076-82.
    View in: PubMed
    Score: 0.003
  108. Bilateral acanthamoeba keratitis. Am J Ophthalmol. 2008 Feb; 145(2):193-197.
    View in: PubMed
    Score: 0.002
  109. Peripheral corneal ulceration in a patient with AIDS-related complex. Am J Ophthalmol. 1987 Nov 15; 104(5):542-3.
    View in: PubMed
    Score: 0.002
  110. Primary Sj?gren's syndrome after infectious mononucleosis. JAMA. 1987 Feb 27; 257(8):1049-50.
    View in: PubMed
    Score: 0.002
  111. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years. Ophthalmology. 2005 Oct; 112(10):1790-4.
    View in: PubMed
    Score: 0.002
  112. Infectious keratitis after LASIK. Ophthalmology. 2003 Mar; 110(3):503-10.
    View in: PubMed
    Score: 0.002
  113. Recurrent fungal keratitis and endophthalmitis. Cornea. 2000 Jul; 19(4):558-60.
    View in: PubMed
    Score: 0.001
  114. Nontuberculous mycobacterial keratitis in south Florida. Ophthalmology. 1998 Sep; 105(9):1652-8.
    View in: PubMed
    Score: 0.001
  115. Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Cornea. 1997 Mar; 16(2):132-7.
    View in: PubMed
    Score: 0.001
  116. Endophthalmitis associated with microbial keratitis. Ophthalmology. 1996 Nov; 103(11):1864-70.
    View in: PubMed
    Score: 0.001
  117. Therapy of nonnecrotizing anterior scleritis with subconjunctival corticosteroid injection. Ophthalmology. 1995 May; 102(5):718-24.
    View in: PubMed
    Score: 0.001
  118. Effective treatment of phlyctenular keratoconjunctivitis with oral tetracycline. Ophthalmology. 1993 Sep; 100(9):1358-66.
    View in: PubMed
    Score: 0.001
  119. Capnocytophaga endophthalmitis. Ophthalmology. 1993 Apr; 100(4):456-9.
    View in: PubMed
    Score: 0.001
  120. Paracentral rheumatoid corneal ulceration. Clinical features and cyclosporine therapy. Ophthalmology. 1992 Jan; 99(1):80-8.
    View in: PubMed
    Score: 0.001
  121. Fulminant pseudomonal keratitis and scleritis in human immunodeficiency virus-infected patients. Arch Ophthalmol. 1991 Apr; 109(4):503-5.
    View in: PubMed
    Score: 0.001
  122. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology. 1991 Feb; 98(2):227-38.
    View in: PubMed
    Score: 0.001
  123. Penetrating ocular injury from contaminated eating utensils. Arch Ophthalmol. 1991 Jan; 109(1):63-6.
    View in: PubMed
    Score: 0.001
  124. Topical anesthetic abuse. Ophthalmology. 1990 Aug; 97(8):967-72.
    View in: PubMed
    Score: 0.001
  125. Detection of herpes viral genomes in normal and diseased corneal epithelium. Curr Eye Res. 1990 Jun; 9(6):569-81.
    View in: PubMed
    Score: 0.001
  126. Endogenous Candida endophthalmitis. Management without intravenous amphotericin B. Ophthalmology. 1990 May; 97(5):666-72; disc: 672-4.
    View in: PubMed
    Score: 0.001
  127. Mycobacterium tuberculosis scleritis. Am J Ophthalmol. 1989 Dec 15; 108(6):736-7.
    View in: PubMed
    Score: 0.001
  128. Management options for Propionibacterium acnes endophthalmitis. Ophthalmology. 1989 Jul; 96(7):1100-5.
    View in: PubMed
    Score: 0.001
  129. Coagulase-negative staphylococcal endophthalmitis. Increase in antimicrobial resistance. Ophthalmology. 1988 Oct; 95(10):1404-10.
    View in: PubMed
    Score: 0.001
  130. Necrotizing keratitis caused by Capnocytophaga ochracea. Am J Ophthalmol. 1988 Jun 15; 105(6):655-60.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.